Abstract
Pulmonary fibrosis is a common consequence of many lung diseases and a leading cause of morbidity and mortality. The molecular mechanisms underlying the development of pulmonary fibrosis remain poorly understood. One model used successfully to study pulmonary fibrosis over the past few decades is the bleomycin-induced pulmonary fibrosis model. We aimed to identify the genes associated with fibrogenesis using an Affymetrix GeneChip system in a bleomycin-induced rat model for pulmonary fibrosis. To confirm fibrosis development, several analyses were performed, including cellular evaluations using bronchoalveolar lavage fluid, measurement of lactate dehydrogenase activity, and histopathological examinations. Common aspects of pulmonary fibrosis such as prolonged inflammation, immune cell infiltration, emergence of fibroblasts, and deposition of extracellular matrix and connective tissue elements were observed. Global gene expression analysis revealed significantly altered expression of genes (≥ 1.5-fold, p < 0.05.) in a time-dependent manner during the development of pulmonary fibrosis. Our results are consistent with previous results of well-documented gene expression. Interestingly, the expression of triggering receptor expressed on myeloid cells 2 (Trem2), secreted phosphoprotein 1 (Spp1), and several proteases such as Tpsab1, Mcpt1, and Cma1 was considerably induced in the lung after bleomycin treatment, despite little evidence that they are involved in pulmonary fibrogenesis. These data will aid in our understanding of fibrogenic mechanisms and contribute to the identification of candidate biomarkers of fibrotic disease development.
Article PDF
Similar content being viewed by others
References
Ashcroft, T., Simpson, J.M. and Timbrell, V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol., 41, 467–470.
Belperio, J.A., Keane, M.P., Burdick, M.D., Lynch, J.P., 3rd, Xue, Y.Y., Berlin, A., Ross, D.J., Kunkel, S.L., Charo, I.F. and Strieter, R.M. (2001). Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J. Clin. Invest., 108, 547–556.
Cortijo, J., Cerda-Nicolas, M., Serrano, A., Bioque, G., Estrela, J.M., Santangelo, F., Esteras, A., Llombart-Bosch, A. and Morcillo, E.J. (2001). Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur. Respir. J., 17, 1228–1235.
Doucet, C., Brouty-Boye, D., Pottin-Clemenceau, C., Canonica, G.W., Jasmin, C. and Azzarone, B. (1998). Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J. Clin. Invest., 101, 2129–2139.
Fertin, C., Nicolas, J.F., Gillery, P., Kalis, B., Banchereau, J. and Maquart, F.X. (1991). Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell. Mol. Biol., 37, 823–829.
Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R.K. and Kitani, A. (2006). IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med., 12, 99–106.
Gharaee-Kermani, M., Hu, B., Phan, S.H. and Gyetko, M.R. (2008). The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy. Expert. Opin. Investig. Drugs, 17, 905–916.
Gharaee-Kermani, M. and Phan, S.H. (2005). Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr. Pharm. Des., 11, 3943–3971.
Gharaee-Kermani, M., Ullenbruch, M. and Phan, S.H. (2005). Animal models of pulmonary fibrosis. Methods Mol. Med., 117, 251–259.
Gorelik, L. and Flavell, R.A. (2002). Transforming growth factorbeta in T-cell biology. Nat. Rev. Immunol., 2, 46–53.
Hoffmann, K.F., McCarty, T.C., Segal, D.H., Chiaramonte, M., Hesse, M., Davis, E.M., Cheever, A.W., Meltzer, P.S., Morse, H.C., 3rd and Wynn, T.A. (2001). Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. Faseb. J., 15, 2545–2547.
Jakubzick, C., Choi, E.S., Carpenter, K.J., Kunkel, S.L., Evanoff, H., Martinez, F.J., Flaherty, K.R., Toews, G.B., Colby, T.V., Travis, W.D., Joshi, B.H., Puri, R.K., and Hogaboam, C.M. (2004). Human pulmonary fibroblasts exhibit altered interleu-kin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am. J. Pathol., 164, 1989–2001.
Jordana, M., Dolovich, M., Irving, L.B., Tomioka, M., Befus, D., Gauldie, J. and Newhouse, M.T. (1988). Solute movement across the alveolar-capillary membrane after intratracheally administered bleomycin in rats. Am. Rev. Respir. Dis., 138, 96–100.
Kaminski, N., Allard, J.D., Pittet, J.F., Zuo, F., Griffiths, M.J., Morris, D., Huang, X., Sheppard, D. and Heller, R.A. (2000). Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc. Natl. Acad. Sci. USA, 97, 1778–1783.
Kang, H.R., Cho, S.J., Lee, C.G., Homer, R.J. and Elias, J.A. (2007). Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. J. Biol. Chem., 282, 7723–7732.
Katsuma, S., Nishi, K., Tanigawara, K., Ikawa, H., Shiojima, S., Takagaki, K., Kaminishi, Y., Suzuki, Y., Hirasawa, A., Yano J., Murakami, Y. and Tsujimoto G. (2001). Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microar-ray-based gene expression profiling. Biochem. Biophys. Res. Commun., 288, 747–751.
Kuwano, K., Hagimoto, N. and Hara, N. (2001). Molecular mechanisms of pulmonary fibrosis and current treatment. Curr. Mol. Med., 1, 551–573.
Lloyd, C.M., Minto, A.W., Dorf, M.E., Proudfoot, A., Wells, T.N., Salant, D.J. and Gutierrez-Ramos, J.C. (1997). RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med., 185, 1371–1380.
Ma, B., Zhu, Z., Homer, R.J., Gerard, C., Strieter, R. and Elias, J.A. (2004). The C10/CCL6 chemokine and CCR1 play critical roles in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol., 172, 1872–1881.
Matsui, Y., Jia, N., Okamoto, H., Kon, S., Onozuka, H., Akino, M., Liu, L., Morimoto, J., Rittling, S.R., Denhardt, D., Kitabatake, A. and Uede, T. (2004). Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension, 43, 1195–1201.
Moeller, A., Ask, K., Warburton, D., Gauldie, J. and Kolb, M. (2008). The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int. J. Biochem. Cell Biol., 40, 362–382.
Moore, B.B., Paine, R., 3rd, Christensen, P.J., Moore, T.A., Sitterding, S., Ngan, R., Wilke, C.A., Kuziel, W.A. and Toews, G.B. (2001). Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol., 167, 4368–4377.
Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J., Pittet, J.F., Kaminski, N., Garat, C., Matthay, M.A., Rifkin, D.B. and Sheppard, D. (1999). The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell, 96, 319–328.
Murray, L.A., Argentieri, R.L., Farrell, F.X., Bracht, M., Sheng, H., Whitaker, B., Beck, H., Tsui, P., Cochlin, K., Evanoff, H.L., Hogaboam, C.M. and Das, A.M. (2008). Hyperresponsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int. J. Biochem. Cell. Biol., 40, 2174–2182.
Oh, J.H., Yang, M.J., Yang, Y.S., Park, H.J., Heo, S.H., Lee, E.H., Song, C.W. and Yoon, S. (2009). Microarray-based analysis of the lung recovery process after stainless-steel welding fume exposure in Sprague-Dawley rats. Inhal. Toxicol., 21, 347–373.
Perbal, B. (2004). CCN proteins: multifunctional signalling regulators. Lancet, 363, 62–64.
Piguet, P.F., Collart, M.A., Grau, G.E., Sappino, A.P. and Vassalli, P. (1990). Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature, 344, 245–247.
Pottier, N., Chupin, C., Defamie, V., Cardinaud, B., Sutherland, R., Rios, G., Gauthier, F., Wolters, P.J., Berthiaume, Y., Barbry, P. and Mari, B. (2007). Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3? Am. J. Respir. Crit. Care. Med., 176, 1098–1107.
Prasse, A., Stahl, M., Schulz, G., Kayser, G., Wang, L., Ask, K., Yalcintepe, J., Kirschbaum, A., Bargagli, E., Zissel, G., Kolb, M., Muller-Quernheim, J., Weiss, J.M. and Renkl, A.C. 2009. Essential role of osteopontin in smoking-related interstitial lung diseases. Am. J. Pathol., 174, 1683–1691.
Roberts, A.B., Russo, A., Felici, A. and Flanders, K.C. (2003). Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann. N. Y. Acad. Sci., 995, 1–10.
Sakanashi, Y., Takeya, M., Yoshimura, T., Feng, L., Morioka, T. and Takahashi, K. (1994). Kinetics of macrophage subpopula-tions and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1. J. Leukoc. Biol., 56, 741–750.
Sandler, N.G., Mentink-Kane, M.M., Cheever, A.W. and Wynn, T.A. (2003). Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol., 171, 3655–3667.
Selman, M., Thannickal, V.J., Pardo, A., Zisman, D.A., Martinez, F.J. and Lynch, J.P., 3rd. (2004). Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs, 64, 405–430.
Sime, P.J., Xing, Z., Graham, F.L., Csaky, K.G. and Gauldie, J. (1997). Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J. Clin. Invest., 100, 768–776.
Smith, R.E., Strieter, R.M., Zhang, K., Phan, S.H., Standiford, T.J., Lukacs, N.W. and Kunkel, S.L. (1995). A role for C-C chemok-ines in fibrotic lung disease. J. Leukoc. Biol., 57, 782–787.
Tokuda, A., Itakura, M., Onai, N., Kimura, H., Kuriyama, T. and Matsushima, K. (2000). Pivotal role of CCR1-positive leukocytes in bleomycin-induced lung fibrosis in mice. J. Immunol., 164, 2745–2751.
van den Brule, S., Misson, P., Buhling, F., Lison, D. and Huaux, F. (2005). Overexpression of cathepsin K during silica-induced lung fibrosis and control by TGF-beta. Respir. Res., 6, 84.
Wynn, T.A. (2004). Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol., 4, 583–594.
Wynn, T.A., Cheever, A.W., Jankovic, D., Poindexter, R.W., Caspar, P., Lewis, F.A. and Sher, A. (1995). An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature, 376, 594–596.
Zhang, H.Y., Gharaee-Kermani, M., Zhang, K., Karmiol, S. and Phan, S.H. (1996). Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am. J. Pathol., 148, 527–37.
Zhang, K., Gharaee-Kermani, M., Jones, M.L., Warren, J.S. and Phan, S.H. (1994). Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol., 153, 4733–4741.
Zhu, Z., Homer, R.J., Wang, Z., Chen, Q., Geba, G.P., Wang, J., Zhang, Y. and Elias, J.A. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, sub-epithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest., 103, 779–788.
Zuo, F., Kaminski, N., Eugui, E., Allard, J., Yakhini, Z., Ben-Dor, A., Lollini, L., Morris, D., Kim, Y., DeLustro, B., Sheppard, D., Pardo, A., Selman, M. and Heller, R.A. (2002). Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. USA, 99, 6292–6297.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Park, HJ., Yang, MJ., Oh, JH. et al. Genome-Wide Transcriptional Response During the Development of Bleomycin-Induced Pulmonary Fibrosis in Sprague-Dawley Rats. Toxicol Res. 26, 137–147 (2010). https://doi.org/10.5487/TR.2010.26.2.137
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2010.26.2.137